JP2024534783A5 - - Google Patents
Info
- Publication number
- JP2024534783A5 JP2024534783A5 JP2024509014A JP2024509014A JP2024534783A5 JP 2024534783 A5 JP2024534783 A5 JP 2024534783A5 JP 2024509014 A JP2024509014 A JP 2024509014A JP 2024509014 A JP2024509014 A JP 2024509014A JP 2024534783 A5 JP2024534783 A5 JP 2024534783A5
- Authority
- JP
- Japan
- Prior art keywords
- modified immune
- immune cell
- cell according
- domain
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021113239 | 2021-08-18 | ||
| CNPCT/CN2021/113239 | 2021-08-18 | ||
| CNPCT/CN2021/122129 | 2021-09-30 | ||
| CN2021122129 | 2021-09-30 | ||
| CNPCT/CN2021/133061 | 2021-11-25 | ||
| CN2021133061 | 2021-11-25 | ||
| CNPCT/CN2022/112578 | 2022-08-15 | ||
| CN2022112578 | 2022-08-15 | ||
| PCT/CN2022/113170 WO2023020558A1 (en) | 2021-08-18 | 2022-08-18 | Modified immune cells expressing tlr receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534783A JP2024534783A (ja) | 2024-09-26 |
| JP2024534783A5 true JP2024534783A5 (enExample) | 2025-08-15 |
Family
ID=85240048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509014A Pending JP2024534783A (ja) | 2021-08-18 | 2022-08-18 | Ｔｌｒ受容体を発現する改変された免疫細胞 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240350545A1 (enExample) |
| EP (1) | EP4392463A4 (enExample) |
| JP (1) | JP2024534783A (enExample) |
| KR (1) | KR20240055733A (enExample) |
| CN (1) | CN117580870A (enExample) |
| AU (1) | AU2022330883A1 (enExample) |
| CA (1) | CA3229493A1 (enExample) |
| TW (1) | TW202328435A (enExample) |
| WO (1) | WO2023020558A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024251225A1 (en) * | 2023-06-07 | 2024-12-12 | Nanjing Legend Biotech Co., Ltd. | Rapamycin resistant cells and methods of use thereof |
| JP2026523614A (ja) * | 2023-07-07 | 2026-07-14 | オーバーランド セラピューティクス （ユーエス） インコーポレイテッド | Ｇｐｒｃ５ｄに対する単一ドメイン抗体 |
| WO2026158639A1 (en) * | 2025-01-26 | 2026-07-30 | Nanjing Legend Biotech Co., Ltd. | Bcma binding moieties and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201513540D0 (en) * | 2015-07-31 | 2015-09-16 | King S College London | Therapeutic agents |
| CN107207613B (zh) * | 2015-08-07 | 2020-06-09 | 深圳市体内生物医药科技有限公司 | 含Toll样受体胞内结构域的嵌合抗原受体 |
| CN106220736B (zh) * | 2016-07-20 | 2020-01-10 | 深圳市体内生物医药科技有限公司 | 一种嵌合抗原受体、表达其的细胞及其制备方法和用途 |
| US11654158B2 (en) * | 2016-11-17 | 2023-05-23 | 2Seventy Bio, Inc. | TGFBeta signal convertor |
| CN106749675B (zh) * | 2016-12-27 | 2022-05-27 | 深圳市体内生物医药科技有限公司 | 一种重组慢病毒及其应用 |
| DK3688032T3 (da) * | 2017-09-26 | 2025-12-15 | Cero Therapeutics Holdings Inc | Kimære engulfment-receptormolekyler og anvendelsesfremgangsmåder |
| WO2020052543A1 (en) * | 2018-09-10 | 2020-03-19 | Nanjing Legend Biotech Co., Ltd. | Single-domain antibodies against cd33 and constructs thereof |
| US20220096547A1 (en) * | 2019-01-03 | 2022-03-31 | Nanjing Legend Biotech Co., Ltd. | Modified immune cells expressing flagellin polypeptide |
| EP3937974A1 (en) * | 2019-03-11 | 2022-01-19 | Leucid Bio Ltd | Muc1 parallel car (pcar) therapeutic agents |
| CN110904048A (zh) * | 2019-12-04 | 2020-03-24 | 合肥中科干细胞再生医学有限公司 | 一种car-cd123t2嵌合抗原受体t细胞及其应用 |
| CN111875710A (zh) * | 2020-07-31 | 2020-11-03 | 广东昭泰体内生物医药科技有限公司 | 异质性肿瘤治疗用免疫细胞及其应用 |
| CN112210018A (zh) * | 2020-10-12 | 2021-01-12 | 广东昭泰体内生物医药科技有限公司 | 一种靶向gpc3的嵌合抗原受体及其应用 |
-
2022
- 2022-08-18 KR KR1020247005287A patent/KR20240055733A/ko active Pending
- 2022-08-18 TW TW111131118A patent/TW202328435A/zh unknown
- 2022-08-18 CA CA3229493A patent/CA3229493A1/en active Pending
- 2022-08-18 US US18/683,208 patent/US20240350545A1/en active Pending
- 2022-08-18 AU AU2022330883A patent/AU2022330883A1/en active Pending
- 2022-08-18 CN CN202280042056.6A patent/CN117580870A/zh active Pending
- 2022-08-18 WO PCT/CN2022/113170 patent/WO2023020558A1/en not_active Ceased
- 2022-08-18 JP JP2024509014A patent/JP2024534783A/ja active Pending
- 2022-08-18 EP EP22857869.6A patent/EP4392463A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11180553B2 (en) | Chimeric antigen receptor | |
| TWI800506B (zh) | 免疫結合物 | |
| JP6936497B2 (ja) | 多価Ｆｖ抗体 | |
| CN111234033B (zh) | 多链嵌合抗原受体及其用途 | |
| JP2025081360A (ja) | 免疫療法のための操作されたナチュラルキラー細胞と操作されたｔ細胞の組み合わせ | |
| AU2021383237B2 (en) | Nkg2a-targeting antibody and use thereof | |
| JP2022109953A5 (enExample) | ||
| GB2611448A (en) | Polypeptide useful in adoptive cell therapy | |
| CN112912401B (zh) | 抗-l1细胞粘附分子抗体或其抗原结合片段及包含其的嵌合抗原受体 | |
| JP2023527049A5 (enExample) | ||
| JP2022523961A5 (enExample) | ||
| CN114763385B (zh) | 靶向ror1的抗体及其用途 | |
| JP2019525771A5 (enExample) | ||
| EP3735417A1 (en) | Multi-domain immunomodulatory proteins and methods of use thereof | |
| WO2013185552A1 (zh) | 双信号独立的嵌合抗原受体及其用途 | |
| JP7227630B2 (ja) | Ｙ１８２ｔ突然変異を有するｔ細胞－抗原カプラおよびその方法ならびに使用 | |
| JP2022513372A5 (enExample) | ||
| US20230242638A1 (en) | Chimeric antigen receptor targeting cldn18.2 and use thereof | |
| JP2022529380A5 (enExample) | ||
| JP2022548112A5 (enExample) | ||
| US12540195B2 (en) | CS1-antibody and anti-CS1-CAR-T cells | |
| KR20230072536A (ko) | 인간화된 cd22에 특이적인 항체 및 이를 이용한 키메라 항원 수용체 | |
| JP7509367B2 (ja) | Ｃｄ２６特異的キメラ抗原受容体 | |
| JP2024513485A5 (enExample) | ||
| WO2025223413A1 (zh) | 抗cd70嵌合抗原受体及其用途 |